Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays
暂无分享,去创建一个
D. Hoon | Makoto Nagahara | Shigeshi Ono | Stella Lam | Dave S. B. Hoon | Stella Lam | Shigeshi Ono | Makoto Nagahara
[1] Muneesh Tewari,et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). , 2010, Methods.
[2] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[3] M. Tewari,et al. MicroRNA profiling: approaches and considerations , 2012, Nature Reviews Genetics.
[4] Thomas J. Wang,et al. Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training , 2011, The Journal of physiology.
[5] K. Shadan,et al. Available online: , 2012 .
[6] Thomas Ragg,et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements , 2006, BMC Molecular Biology.
[7] M. Ares,et al. Guidelines for the use of RNA purification kits. , 2010, Cold Spring Harbor Protocols.
[8] Hugh S Markus,et al. Circulating MicroRNAs as Novel Biomarkers for Platelet Activation , 2013, Circulation research.
[9] Stefan Holdenrieder,et al. MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels , 2011, PloS one.
[10] Toby C. Cornish,et al. A Critical Evaluation of microRNA Biomarkers in Non-Neoplastic Disease , 2014, PloS one.
[11] Melissa G. Piper,et al. Analyzing the circulating microRNAs in exosomes/extracellular vesicles from serum or plasma by qRT-PCR. , 2013, Methods in molecular biology.
[12] Paula K Shireman,et al. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis , 2009 .
[13] C. Croce,et al. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives , 2010, Cell Death and Differentiation.
[14] T. Nakazawa,et al. Profiles of Extracellular miRNAs in the Aqueous Humor of Glaucoma Patients Assessed with a Microarray System , 2014, Scientific Reports.
[15] Á. Zaballos,et al. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival , 2010, European Respiratory Journal.
[16] Jessica A. Weber,et al. The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.
[17] E. Kroh,et al. Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels , 2013, PloS one.
[18] M. Ares,et al. Purification of RNA using TRIzol (TRI reagent). , 2010, Cold Spring Harbor protocols.
[19] J. Blanco,et al. Anticoagulants Interfere with PCR Used To Diagnose Invasive Aspergillosis , 2002, Journal of Clinical Microbiology.
[20] Michael L. Wang,et al. Effect of Long-term Storage in TRIzol on Microarray-Based Gene Expression Profiling , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[21] B. Reinhart,et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.
[22] C. Belka,et al. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients , 2013, Radiation Oncology.
[23] W. Al-Soud,et al. Purification and Characterization of PCR-Inhibitory Components in Blood Cells , 2001, Journal of Clinical Microbiology.
[24] J. Byrd,et al. Circulating miRNA markers show promise as new prognosticators for multiple myeloma , 2014, Leukemia.
[25] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[26] M. Mayr,et al. Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease , 2013, Thrombosis and Haemostasis.
[27] C. Atreya,et al. Differential profiling of human red blood cells during storage for 52 selected microRNAs , 2010, Transfusion.
[28] T Kawaguchi,et al. Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma , 2014, British Journal of Cancer.
[29] Sota Asaga,et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. , 2011, Clinical chemistry.
[30] C. Stephan,et al. Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. , 2010, Clinical chemistry.
[31] Antai Wang,et al. Exploration of Genome-Wide Circulating MicroRNA in Hepatocellular Carcinoma: MiR-483-5p as a Potential Biomarker , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[32] Xi Chen,et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] David J. Galas,et al. Comparing the MicroRNA Spectrum between Serum and Plasma , 2012, PloS one.
[34] Hongbing Shen,et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer , 2014, British Journal of Cancer.
[35] Vlad I. Morariu,et al. Expression , 2015, Principles of Molecular Virology.
[36] V. Beneš,et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.
[37] Z. Du,et al. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma. , 2015, Cancer biomarkers : section A of Disease markers.
[38] Michael F. Ochs,et al. Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer , 2012, PloS one.
[39] Lianbo Yu,et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.
[40] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[41] Kenneth W Witwer,et al. Circulating microRNA biomarker studies: pitfalls and potential solutions. , 2015, Clinical chemistry.
[42] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[43] C. Croce. Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.
[44] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[45] Joon Cheol Park,et al. Plasma components affect accuracy of circulating cancer-related microRNA quantitation. , 2012, The Journal of molecular diagnostics : JMD.
[46] F. Nicolantonio,et al. Liquid biopsy: monitoring cancer-genetics in the blood , 2013, Nature Reviews Clinical Oncology.
[47] J. Tosar,et al. Assessment of small RNA sorting into different extracellular fractions revealed by high-throughput sequencing of breast cell lines , 2015, Nucleic acids research.
[48] Feng Jiang,et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers , 2011, BMC Cancer.
[49] Paul Bertone,et al. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. , 2010, RNA.
[50] Stefanie Dimmeler,et al. Circulating MicroRNAs in Patients With Coronary Artery Disease , 2010, Circulation research.
[51] F. B. Sørensen,et al. Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer , 2015, British Journal of Cancer.
[52] G. Reid,et al. Cell-free microRNAs: potential biomarkers in need of standardized reporting , 2013, Front. Genet..
[53] Zheng Wang,et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] Yanhong Zhou,et al. Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma , 2012, PloS one.
[55] J. McHugh,et al. Do Platform-Specific Factors Explain MicroRNA Profiling Disparities? , 2012 .
[56] A. Schetter,et al. Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer , 2012, International journal of cancer.
[57] D. Hoon,et al. A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients , 2015, Oncotarget.
[58] H. Mann,et al. Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis , 2013, Annals of the rheumatic diseases.
[59] V. Ambros. microRNAs Tiny Regulators with Great Potential , 2001, Cell.
[60] Klaus Pantel,et al. Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.
[61] F. Slack,et al. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy , 2011, Nature Reviews Cancer.
[62] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[63] N. Kosaka,et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells , 2014, Science Signaling.
[64] R. Elashoff,et al. Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] Wei Li,et al. MicroRNA detection by microarray , 2009, Analytical and bioanalytical chemistry.
[66] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[67] Federica Limana,et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction , 2010, European heart journal.
[68] S. Fichtlscherer,et al. Heparin selectively affects the quantification of microRNAs in human blood samples. , 2013, Clinical chemistry.
[69] E. Lianidou,et al. Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. , 2013, The Journal of molecular diagnostics : JMD.
[70] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[71] Lynne T. Bemis,et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.
[72] V. Kim. MicroRNA biogenesis: coordinated cropping and dicing , 2005, Nature Reviews Molecular Cell Biology.
[73] Feng Jiang,et al. Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer , 2013, Journal of Cancer Research and Clinical Oncology.
[74] V. Kim,et al. Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. , 2012, Molecules and Cells.
[75] Tania Nolan,et al. The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments. , 2013, Clinical chemistry.
[76] D. Hoon,et al. Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients , 2013, Expert review of molecular diagnostics.
[77] Massimo Bellomi,et al. miR-Test: a blood test for lung cancer early detection. , 2015, Journal of the National Cancer Institute.
[78] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[79] Hailong Xie,et al. U6 is not a suitable endogenous control for the quantification of circulating microRNAs. , 2014, Biochemical and biophysical research communications.
[80] D. Hoon,et al. Direct serum assay for microRNA in cancer patients. , 2013, Methods in molecular biology.
[81] Alicia Algeciras-Schimnich,et al. Analysis of circulating microRNA: preanalytical and analytical challenges. , 2011, Clinical chemistry.